Glutathione 500 mg vial price

No injectable glutathione product is FDA-approved in the United States. Several national regulators, including the Philippine FDA, have issued explicit advisories against IV use for skin lightening. Why did the FDA warn about compounded glutathione injections in 2026? On August 27, 2026, the FDA reported at least 30 patients with adverse events after IV glutathione, alone or mixed with other ingredients, including fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms; some were hospitalized, and the pattern was consistent with excessive endotoxin exposure. Every linked product traced to dietary supplement grade powder from one supplier and one lot, pointing to ingredient grade and endotoxin rather than the molecule itself; the supplier told the FDA on August 20, 2026 that it had warned its US customers not to use the powder in injectables. Two Texas pharmacies recalled glutathione injectables over elevated endotoxin, and the FDA had raised the same concern in 2019. The CDC investigation page, updated September 15, 2026, reported over 25 people sick in at least four states, Texas, Washington, Florida and New York, with at least three hospitalized and one critically ill; the CDC says its count may change. A research-chemical vial has no pharmacy behind it at all, so the one check available is whether the lot's certificate reports an endotoxin (LAL) result.